FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

33589311000001104: Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Nov 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2113001000001115 Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2113021000001110 Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101300601000001115 Cilostazol 50mg tablets (Mylan Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
101300701000001113 Cilostazol 50mg tablets (Mylan Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
105733901000001113 Cilostazol 50mg tablets (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Is a Product containing precisely cilostazol 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Cilostazol false Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Cilostazol true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) 56 tablet Has AMP True Cilostazol 50mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start